A CO Down IT firm has announced a new deal with an emerging German medtech business.
Holywood-based cloud solutions specialist 3EN secured the contract with Hemovent, which creates miniaturised heart-lung machines that can be used to temporarily support or replace heart and lung function in patients with acute respiratory or circulatory failure.
The German company has reported a rise in demand for its devices from hospitals treating patients for the effects of Covid-19.
Dale Cree, chief executive of 3EN, said: “The need for digital transformation has never been more evident than during Covid-19.
“We are honoured to be working with Hemovent as they expand their business across the world and support the global fight against Covid-19. The cloud technology we offer will support the company’s continued growth and we look forward to working with the team long into the future.”
Christof Lenz, from Hemovent, added: “We have seen rapid growth in business in 2020 and needed cloud technology that supported our expansion and encouraged efficiency across the company.
“The team at 3EN delivered an excellent service implementing Oracle NetSuite into the business, allowing us to focus on the development of our ground-breaking ExtraCorporeal Membrane Oxygenation (ECMO) devices that are currently in high demand due to COVID-19.
“We are grateful that our efforts are now supported by another highly renowned European company.”
Hemovent will be supported by 3EN’s offices in Bonn, Germany and Holywood, Northern Ireland.
